Technology News and Research

RSS

USPTO issues five patents to VertiFlex Superion ISS

VertiFlex, Inc., a leading innovator of advanced minimally invasive spinal surgery technologies, today announced that the U.S. Patent and Trademark Office has awarded five additional key patents covering the design and implantation method for its unique interspinous spacer technology. The five U.S. patent numbers are 8,012,207, 8,123,807, 8,123,782, 8,128,662, and 8,152,837.

11 Apr 2012

Boston Scientific receives European CE Mark approval for INGENIO family of pacemakers

Boston Scientific Corporation announces CE Mark approval and European market launch of its INGENIO and ADVANTIO pacemakers and INVIVE cardiac resynchronization therapy pacemakers.

11 Apr 2012

NYU Langone announces opening of Center for Musculoskeletal Care

NYU Langone Medical Center ushered in the next generation of orthopaedic, rheumatologic and rehabilitative care with the opening of the Center for Musculoskeletal Care (CMC) at 333 East 38th Street in Manhattan last week.

11 Apr 2012

Intact Vascular’s Tack-it Endovascular Stapler device receives CE Mark approval

Intact Vascular, a medical device company and developer of products for minimally invasive peripheral vascular procedures, today announced its European notified body has granted the company ISO Certification and CE Mark approval for Tack-it Endovascular Stapler device.

11 Apr 2012

3M announces acquisition of CodeRyte

3M announced today that it has acquired CodeRyte Inc., an industry leader in clinical natural language processing (NLP) technology and computer-assisted coding solutions for healthcare outpatient providers.

11 Apr 2012

Genstar Capital enters definitive agreement to acquire ERT

eResearchTechnology, Inc. (ERT), a global technology-driven provider of health outcomes research services to biopharmaceutical sponsors and contract research organizations (CROs), today announced that it has entered into a definitive agreement to be acquired by affiliates of Genstar Capital LLC, a leading middle market private equity firm for $8.00 per share in cash in a transaction valued at approximately $400 million.

10 Apr 2012

Lee's Pharma licenses rights to commercialize PL2200 Aspirin in China

PLx Pharma Inc, a Houston based pharmaceutical company developing gastrointestinal (GI) safer drugs has licensed to Lee's Pharmaceutical Holdings Limited (Lee's Pharma) the rights to register and commercialize in China, Hong Kong and Macau the PL2200 Aspirin, a GI safer aspirin product currently in development in the US, for prevention of cardiovascular diseases. Cardiovascular is one of the focus areas of Lee's Pharma.

10 Apr 2012

FDA selects three renal device projects for new Pathway program

A UCSF-led effort to create an implantable artificial kidney for dialysis patients has been selected as one of the first projects to undergo more timely and collaborative review at the Food and Drug Administration.

10 Apr 2012

Low-dose spiral CT cost-effective in reducing lung cancer deaths

Lung cancer is the most lethal cancer in the United States. According to the National Cancer Institute, lung cancer causes more than 150,000 deaths annually and has a survival rate of 16 percent. More Americans die of lung cancer each year than of cervical, breast, colon and prostate cancers combined.

10 Apr 2012

Three NJIT EDC high-tech companies win top awards at 2012 Venture Conference

Three high-tech companies based at NJIT's Enterprise Development Center (EDC) took top awards at the recent 2012 Venture Conference sponsored by the New Jersey Technology Council.

10 Apr 2012

Reprogramming the Brain to Health Symposium to take place on April 12

Jordan Grafman, PhD, will speak at the Reprogramming the Brain to Health Symposium at The University of Texas at Dallas on April 12. An expert on brain function and behavior, Dr. Grafman's topic is human belief systems in the brain.

10 Apr 2012

First study to demonstrate link between social status and genetic regulation in primates

The ranking of a monkey within her social environment and the stress accompanying that status dramatically alters the expression of nearly 1,000 genes, a new scientific study reports. The research is the first to demonstrate a link between social status and genetic regulation in primates on a genome-wide scale, revealing a strong, plastic link between social environment and biology.

10 Apr 2012

Changes in corneal thickness occur in patients at early stages of FECD

A national consortium of researchers has published new findings that could change the standard of practice for those treating Fuchs' Endothelial Corneal Dystrophy (FECD), a disease characterized by cornea swelling that can eventually lead to the need for corneal transplantation.

10 Apr 2012

ACC designates USF Health CAMLS as first Center of Excellence in Education and Training

The American College of Cardiology has designated the USF Health Center of Advanced Learning and Simulation (CAMLS) as its first Center of Excellence in Education and Training.

10 Apr 2012

CEO Roundtable on Cancer accredits Allegeant

The CEO Roundtable on Cancer recently accredited health management company Allegeant, LLC, of Baltimore, Maryland with the CEO Cancer Gold Standard recognizing the staffing company's efforts to reduce the risk of cancer for their employees and covered family members by promoting healthy lifestyle choices, encouraging early detection through cancer screenings and ensuring access to quality treatment.

10 Apr 2012

Three ESRD products chosen for FDA's Innovation Pathway program

Three products for patients with end stage renal disease (ESRD) have been chosen to participate in the FDA's Innovation Pathway, an evolving system designed to help medical devices reach patients in a safe, timely and collaborative manner.

10 Apr 2012

Monitoring necessary for early intervention in Fuchs' Endothelial Corneal Dystrophy patients

10 Apr 2012

Spacelabs Healthcare launches qube patient monitor

Having received clearance under Section 510(k) from the U.S. Food and Drug Administration, Spacelabs Healthcare is adding the qube patient monitor to its Art of Monitoring portfolio. Inspired by the revolutionary style of the company's XPREZZON patient monitor, qube breaks with tradition to offer a fresh, new perspective in compact monitoring.

10 Apr 2012

States roundup: Aetna goes ahead with small biz coverage hike; 1.2M Texas kids without insurance; Legal immigrants join Mass. health plan

Despite criticism from the state insurance commissioner and several statewide consumer groups, Aetna said Thursday it's going ahead with a recent hike in health care premiums for small businesses. Aetna's new increases, which average 8 percent annually and took effect April 1, were deemed "unreasonable" this week by state Department of Insurance Commissioner David Jones.

10 Apr 2012

FDA approves scan to detect Alzheimer’s disease early

The test uses a chemical called florbetapir, known by the brand name Amyvid, which is a radioactive agent that tags clumps of a sticky substance called an amyloid. Amyloid proteins are hallmarks of Alzheimer's disease. The chemical, which costs $1,600 per dose, then is detected using a brain imaging technique called positron emission tomography, known as PET scans. For patients who already have some symptoms of cognitive decline, a positive scan suggests that moderate to frequent amyloid plaques are present in the brain, which is consistent with Alzheimer's disease.

9 Apr 2012